4.7 Article

Antibiotic-Resistant Gram-Negative Bacterial Infections in Patients With Cancer

期刊

CLINICAL INFECTIOUS DISEASES
卷 59, 期 -, 页码 S335-S339

出版社

OXFORD UNIV PRESS INC
DOI: 10.1093/cid/ciu612

关键词

infections; neutropenia; carbapenem-resistant Enterobacteriaceae; Acinetobacter baumannii; Pseudomonas aeruginosa

资金

  1. Cleveland Department of Veterans Affairs [1I01BX001974]
  2. Geriatric Research Education and Clinical Center VISN [10]
  3. National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH) [R01AI063517, R01AI10056]
  4. Antibiotic Resistance Leadership Group (NIH) [UM1AI104681]
  5. Clinical and Translational Science Collaborative of Cleveland from the National Center for Advancing Translational Sciences component of the NIH [UL1TR000439]
  6. Pfizer
  7. STERIS Corporation
  8. AstraZeneca
  9. Merck
  10. Rib-X Pharmaceuticals

向作者/读者索取更多资源

Patients with cancer are at high risk for infections caused by antibiotic resistant gram-negative bacteria. In this review, we summarize trends among the major pathogens and clinical syndromes associated with antibiotic resistant gram-negative bacterial infection in patients with malignancy, with special attention to carbapenem and expanded-spectrum beta-lactam resistance in Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia-all major threats to our cancer patients. Optimal therapy for these antibiotic-resistant pathogens still remains to be determined.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据